Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.

NCT00721695 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract Extraction

Interventions

DRUG: OMS302
DRUG: OMS302-PE
DRUG: Vehicle

Sponsor

Omeros Corporation